Bone Loss Terminated Phase 2 Trials for Zoledronic acid (DB00399)

Also known as: Osteopenia / Osteopaenia

IndicationStatusPhase
DBCOND0031952 (Bone Loss)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00844480Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone LossPrevention